Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - STOCK-BASED COMPENSATION
Stock-based Compensation LRMR - Larimar Therapeutics, Inc.
7.62 M
LAST VALUE
17.96%
2 YEAR CAGR
113.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR